Effectiveness of Bosentan Therapy in Patients With Systemic scleRosis and Progressive Digital ulcEr Disease.

NCT05168215 · clinicaltrials.gov ↗

UNKNOWN

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Scleroderma
Digital Ulcer
Autoimmune Diseases
Diffuse Cutaneous Systemic Sclerosis
Reynold Syndrome

Sponsor

Elpen Pharmaceutical Co. Inc.